PEAK6 Group’s Exact Sciences EXAS Stock Holding History

PEAK6 Group’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16,985	Closed	-$914K	–	4483
2018 Q1	$685K	Buy	16,985 +7,115	+72%	+$347K	﹤0.01%	2300
2017 Q4	$519K	Buy	+9,870	New	+$527K	﹤0.01%	2442

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PEAK6 Group's EXAS Position: Q2 2018 in Review

PEAK6 Group sold out of Exact Sciences (EXAS) in Q2 2018, closing a stake of 16,985 shares — an estimated $914K sold.

PEAK6 Group first reported a position in EXAS in Q4 2017 and held it in 2 quarters. The position peaked at $685K in Q1 2018. 348 funds tracked by Wall St. Rank hold EXAS as of Q2 2018.

PEAK6 Group reported no remaining Exact Sciences position as of Q2 2018 after selling out during the quarter.
PEAK6 Group sold 16,985 Exact Sciences shares in Q2 2018, an estimated $914K.
PEAK6 Group first reported a position in Exact Sciences in Q4 2017 and held it in 2 quarters.
PEAK6 Group's Exact Sciences position peaked at $685K in Q1 2018.
348 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.